PGENPrecigen, Inc.
$6.19+77% 1Y
$6.19
$3.1052 weeks$8.57
Is the price fair?
What PGEN's price assumes
Precigen, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 229× revenue.
229
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 106
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 228
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 106
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 228
- Market capitalisation358.0 million shares, counted Jul 31, 2026
- $2.22B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks